Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy

This document (A59854) is a response-to-comments notice regarding MolDX LCD L39678 on molecular biomarkers for risk stratification of indeterminate pulmonary nodules after bronchoscopy and does not itself state coverage, limitations, or frequency rules. It records the comment period (2023-08-31 to 2023-10-14) and the LCD notice/effective dates (notice begins 2024-08-08; effective 2024-09-22). Consult the final LCD L39678 for the specific coverage criteria and required documentation.

"This document is a response to public comments regarding MolDX LCD L39678 (Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy); it does not itsel..."

Sign up to see full coverage criteria, indications, and limitations.